Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Status:
Completed
Trial end date:
2001-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Combining biological therapy with chemotherapy may kill more
cancer cells.
PURPOSE: Phase II trial to study the effectiveness of chemotherapy with cytarabine and
homoharringtonine and biological therapy with interferon alfa in treating patients with
chronic phase chronic myelogenous leukemia.